Skip to main content
Image of medicine for the treatment of drug resistant tuberculosis (DR-TB). The left hand contains pills from the recently approved BPaLM 6-month shorter regimen treatment and the right hand contains pills from the longer 18 months regimen treatment. Following the validation of shorter regimen by WHO, MSF started supporting the Ministry of Health in implementing shorter regimen for patients affected by DR-TB since 2022 in Sierra Leone. Depending on individual patients’ diagnostic and clinical situation treatment regimens are initiated. Shorter regimens are often preferred by patients and medical professionals as longer treatment can be physically and mentally harder to adhere to.

Antibiotic resistance

A person holds medicine for the treatment of drug-resistant tuberculosis (DR-TB) in his hands. Sierra Leone, 14 December 2023.
© MSF/Ammar Obeidat
Ebola disease in DRC: find out how we're responding
Learn more

What happens when drugs stop working?

A true global health emergency, antibiotic resistance threatens to make simple cuts and diseases that are easy to treat deadly once again.

Bacteria, viruses, parasites and other microbes are always changing to ensure their survival. Some have adapted so well to medical treatment that drugs commonly used to prevent or kill them are no longer effective. These microbes cause drug-resistant infections. Their ability to survive medicines used against them is called antimicrobial resistance (AMR). In the case of bacterial pathogens, for which antibiotics are the most common and important drugs available for treatment, we speak of antibiotic resistance (ABR).

Quick facts

Antibiotic resistance is set to be one of this century’s major public health challenges.
But, few people are aware of this issue, which is also poorly documented.
A report commissioned by the British government in 2016 estimated that as many as 10 million people could die from an antibiotic resistant infection by the year 2050.
video

5 minutes to explain... Antibiotic resistance. A global health priority

5 minutes to explain- antibiotic resistance

Antibiotic resistance is set to be one of this century’s major public health challenges. Few people are aware of this issue, which is also poorly documented. A report commissioned by the British government in 2016 estimated that as many as 10 million people could die from an antibiotic resistant infection by the year 2050. In this 5 minutes to explain video, we look at the issues surrounding antibiotic resistance on a global scale, but also for MSF, and how our teams are tackling this enormous challenge in the countries we work.

GEORGE ONDIJO IS A LAB TECHNICIAN AT NDIWAH HOSPITAL IN HOMA BAY COUNTY. HE IS IN CHARGE OF SPUTUM COLLECTION FOR TUBERCULOSIS DIAGNOSIS. THE USE OF MASK IS MANDATORY TO AVOID CONTAGION.
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site

Antibiotic resistance

Language
English